Press Release

Global Automated External Defibrillator Market to Grow with a CAGR of 7.04% through 2028

Rise in focus towards public access defibrillator and rapidly growing geriatric population with elevated risk of cardiac arrest is expected to drive the Global Automated External Defibrillator Market growth in the forecast period, 2024-2028.

According to TechSci Research report, Global Automated External Defibrillator Market - Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028, the Global Automated External Defibrillator Market has valued at USD 1500.01 Million in 2022 and is anticipated to project steady growth in the forecast period with a CAGR of 7.04% through 2028. The automated electronic defibrillator market is experiencing significant growth driven by several key factors. These include the increasing prevalence of cardiac diseases, a growing geriatric population, and notable technological advancements in the field, supported by substantial investments from market players. The increase in adoption of technologically advanced defibrillator devices, along with the rise in demand for quality medical care, and the prevalence of SCA, are key factors driving the growth of the external defibrillators market. Additionally, the focus on installing defibrillators in public places and the availability of defibrillators in offices, schools, shopping malls, grocery stores, and airports are propelling market growth. Moreover, the emphasis of key market players on public access defibrillators and the implementation of training and awareness programs worldwide are contributing factors to the growth of the external defibrillators market. Furthermore, advancements in the innovation of next-generation external defibrillators to enhance safety and effectiveness are anticipated to create lucrative opportunities in the market. Defibrillators play a vital role in improving industry capabilities by identifying and addressing device-related issues. SCA, a life-threatening condition and the leading cause of death globally, can be successfully treated through early intervention with defibrillation.

According to data published by the British Heart Foundation in August 2022, more than 7.6 million people in the United Kingdom were living with heart or circulatory diseases in 2021. This rising prevalence of cardiovascular diseases has led to an increased demand for automated external defibrillators, ultimately fueling market growth during the forecast period.

Furthermore, the rising number of cardiovascular patients requiring surgical procedures is expected to contribute to the demand for automated external defibrillators, further bolstering market growth. According to the British Heart Foundation's data from January 2022, nearly 284,000 people were awaiting time-critical heart operations and other cardiac procedures by the end of November 2021. This surge in cardiovascular surgeries underscores the need for automated external defibrillators, driving market expansion.

Moreover, technological advancements in the field and increased government support are propelling the market's growth. As an example, in March 2021, the Government House in Australia launched the St. John-branded public access defibrillator, an automated external defibrillator (AED). This collaboration between St John Ambulance Australia and Zoll Medical Australia highlights the commitment to advancing AED technology.

The increasing number of supportive policies by governments, regulatory bodies, and healthcare organizations is expected to drive market growth during the forecast period. For instance, the Social Affairs Commission of the Chamber in Italy approved the proposed law on AEDs in July 2021, as reported by the IRC (Italian Resuscitation Council). The law allocates approximately 10 million EUR (about USD 11.36 million) for the implementation of public access AEDs over the next five years, along with other provisions. In Australia, the government agency SA Ambulance Service (SAAS) recommends early use of defibrillators to improve the chances of survival. Both semiautomatic and automatic AEDs are recommended, while manual defibrillators are reserved for trained professionals. AEDs are also preferred over manual defibrillators in low acuity settings, such as medical clinics and allied health and dental clinics, due to their user-friendly nature.

Technological advancements have resulted in compact and user-friendly modern external defibrillators, requiring less maintenance and offering increased cost-effectiveness. In the U.S., AEDs are priced between USD 900 and 2,000. AED USA offers the Zoll AED Plus Fully Automatic defibrillators at USD 1,699, and the ZOLL AED three semi-automatic at USD 1,895. Manual external defibrillators, on the other hand, range from USD 1,000 to 25,000, according to the WHO. Emerging technology trends in the market include advancements in personal AEDs for home use, utilization of drones to enhance cardiac arrest response, solutions to improve AED tracking, and the integration of IoT and analytics. Rapid Response Revival Research Ltd, an Australian-based company, has developed the world's first personal AED-CellAED-for home use. The device obtained CE Certification in May 2021, enabling the company to commercialize it across Europe.

Overall, the automated external defibrillators market is poised for lucrative growth during the forecast period, driven by the escalating burden of cardiovascular diseases and the continuous launch of advanced automated external defibrillators. However, regulatory constraints and a lack of awareness and early intervention measures regarding sudden cardiac arrest may impede market growth in the coming years.

Browse over 26 market data Figures spread through 91 Pages and an in-depth TOC on "Global Automated External Defibrillator Market


The Global Automated External Defibrillator Market is segmented into product type, by end user, regional distribution, and company.

Based on product type, the fully automated external defibrillators market segment currently dominates the global external defibrillators market by product type and is projected to maintain its dominance during the forecast period. This can be attributed to the growing initiatives by major companies, increased adoption of defibrillators in healthcare facilities, and the implementation of various public access defibrillation programs. On the other hand, the wearable cardioverter defibrillator market segment is expected to experience significant growth in the forecast period due to the rising prevalence of cardiovascular disorders, the growing elderly population, and the user-friendly nature of this non-invasive device.

Based on region, North America segment is expected to grow during the forecast period.  North America has established a significant market share in the external defibrillators sector in 2021 and is projected to maintain its dominance throughout the forecast period. This can be attributed to the increasing installation of external defibrillators in hospitals as well as other public places such as hotels, schools, railway stations, highways, and more. On the other hand, Asia-Pacific is expected to exhibit the highest compound annual growth rate (CAGR) in the external defibrillators market, driven by the growing prevalence of cardiovascular diseases, rising disposable incomes in countries like India and China, escalating healthcare costs, and recent advancements in healthcare infrastructure.

Major companies operating in Global Automated External Defibrillator Market are:

  • Koninklijke Philips N.V.
  • Stryker
  • Zoll Medical Corporation
  • Nihon Kohden Corporation
  • ProgettiSrl
  • Schiller AG
  • MS Westfalia GmbH
  • Bexen Cardio
  • Silverline Meditech Pvt. Ltd.
  • Mediana Co., Ltd.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The rise in the incidence of Sudden Cardiac Arrest, as well as the rise in the use of technologically improved defibrillators devices, are significant drivers driving the growth of the external defibrillators market. Furthermore, the increased emphasis on the installation of defibrillators in public locations, as well as the availability of defibrillators in workplaces, schools, shopping malls, grocery shops, and airports, drive market expansion. Furthermore, an increase in leading market players' focus on public access defibrillators and an increase in the number of training and awareness programmes throughout the world are two factors driving the growth of the external defibrillators market. Furthermore, developments in the creation of next-generation external defibrillators to increase safety and efficacy are expected to provide attractive market prospects.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Global Automated External Defibrillator Market By Product Type (Manual External Defibrillator, Fully Automated External Defibrillator, Wearable Cardioverter Defibrillator), By End User (Hospitals, Pre-Hospitals, Public Access Market, Alternate Care Market, Home), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Automated External Defibrillator Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Automated External Defibrillator Market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Web:  https://www.techsciresearch.com